Centiva Capital, LP Abbott Laboratories Put Options Transaction History

Centiva Capital, LP

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$100.07 - $118.13 $1.38 Million - $1.63 Million	-13,800 Reduced 64.19%	7,700 $877,000
Q2 2024 Aug 14, 2024	BUY	$100.73 - $112.44 $2.17 Million - $2.42 Million	21,500 New	21,500 $2.23 Million
Q4 2023 Feb 14, 2024	SELL	$90.19 - $110.4 $369,779 - $452,640	-4,100 Reduced 73.21%	1,500 $165,000
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $534,968 - $641,872	5,600 New	5,600 $542,000
Q1 2020 May 15, 2020	SELL	$62.82 - $91.86 $4.4 Million - $6.43 Million	-70,000 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$81.84 - $88.74 $4.81 Million - $5.22 Million	58,800 Added 525.0%	70,000 $5.86 Million
Q2 2019 Aug 13, 2019	BUY	$72.88 - $85.0 $816,256 - $952,000	11,200 New	11,200 $942,000

3,185

1.31B

8.74M

7.89M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Centiva Capital, LP with notifications on news.